Related Blog Posts
Stanford scientists identify protein that keeps stem cells poised for action
9 hours ago ago from Ben\'s Stem Cell News
Source: Stanford University Medical Center Date: December 24, 2009 Summary: STANFORD, Calif. — Like a child awaiting the arrival of Christmas, embryonic stem cells exist in a state of permanent anticipation. They must balance the ability to quickly become more specialized cell types with the cellular chaos that could occur should they act too early (stop shaking those presents, kids!). Researchers at the Stanford University School of ...
Related contentScientists identify protein that keeps stem cells poised for action
2 hours ago ago from Technology, iPhone, Mobiles, Nokia, and Gadgets
Like a child awaiting the arrival of Christmas, embryonic stem cells exist in a state of permanent anticipation. They must balance the ability to quickly become more specialized cell types with the cellular chaos that could occur should they act too early (stop shaking those presents, kids!). Researchers at the Stanford University School of Medicine have now identified a critical component, called Jarid2, of this delicate balancing act - one ...
Related contentTesticles Could Be New Source Of Stem Cells
10 hours ago ago from thesecrethealth.com
Scientists from Germany and the UK have found a new source of stem cells that could be as good as embryonic stem cells for researching and developing treatments for a range of serious diseases, but without the ethical problems of embryonic stem cells; the source is routine biopsies of men's testicles. The discovery was the work of researchers from the Universities of Tübingen and Cologne in Germany, and King's College, London, and ...
Related contentMichael Savage on Reality of Embryonic Stem Cell Research – Aired on March 9, 2009
14 hours ago ago from Niche Tip
Michael Savage on Reality of Embryonic Stem Cell Research Aired on March 9, 2009
Related contentPfizer Regenerative Medicine aims at working with Athersys to make valuable therapies for patients
21 hours ago ago from MedCity News
December 23, 2009 by Mary Vanac Leave a Comment CLEVELAND, Ohio Ruth McKernan helped start Pfizer Regenerative Medicine a research-oriented business unit of Pfizer, which calls itself the world's largest research-based pharmaceutical company in July 2008. We see regenerative medicine stem cell-based research and therapy as an emerging area, said McKernan, chief scientific officer for the regenerative medicine unit, during a ...
Related contentRelated News
Nothing to see... move along.
